Clinical Trials Directory

Trials / Sponsors / Galmed Pharmaceuticals Ltd

Galmed Pharmaceuticals Ltd

Industry · 10 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingSingle and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet
Healthy
Phase 12025-12-25
WithdrawnA Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangi
Primary Sclerosing Cholangitis
Phase 22025-06-01
Active Not RecruitingComparing The PK Of Aramchol Meglumine Granules To Aramchol Free Acid Tablets
Healthy
Phase 12025-02-15
CompletedA First-in-Human Study of Single and Multiple Doses of Amilo-5MER in Healthy Subjects
Inflammatory Disease
Phase 12021-03-05
CompletedAn Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of Aramchol
NASH
Phase 12020-06-17
CompletedComparison of Aramchol Concentrations With Once or Twice Daily Dosing
Healthy
Phase 12018-12-08
CompletedStudy of Potential for Drug Interactions Mediated by CYP3A4 Inhibition With Aramchol in Healthy Volunteers
Healthy
Phase 12018-11-12
CompletedPharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered Under Fed Conditions in Heal
Healthy Volunteers
Phase 12016-05-01
TerminatedMedical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study
Gallstones
Phase 22014-10-01
CompletedPharmacokinetics of Single and Multiple Escalating Doses of Aramchol and Food Effect in Healthy Volunteers
Healthy Volunteers
Phase 12014-04-01